Propanc Biopharma (PPCB) Total Current Liabilities (2011 - 2026)
Propanc Biopharma's Total Current Liabilities came in at $3.35 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 39.9% from $5.58 million a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Total Current Liabilities (2011 - 2026) Analysis & Trends
Going back to fiscal Q4 2011, Propanc Biopharma's Total Current Liabilities data covers 56 quarters.
- Total Current Liabilities carries a five-year compound annual growth rate of 1.7% (FY2021 to FY2026).
- Going back by fiscal year, Total Current Liabilities was $5.58 million in FY2025 (+47.1%), $3.79 million in FY2024 (+20.1%), $3.16 million in FY2023 (+3.1%) and $3.06 million in FY2022 (-0.6%).
- The fiscal Q4 2026 figure represents the lowest quarterly Total Current Liabilities since fiscal Q1 2024.
- Year-over-year, Total Current Liabilities increased in four of the last seven quarters, with growth averaging 5.8%.
- The fastest year-over-year change in Total Current Liabilities over five years came in fiscal Q4 2025 (growth of 47.1%), and the weakest in fiscal Q4 2026 (a decline of 39.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.41 Bn | 1,108.99 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 618.57 Bn | 537.10 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 509.95 Bn | 483.06 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 366.63 Bn | 321.01 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 298.47 Bn | 262.46 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 263.21 Bn | 236.89 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 236.71 Bn | 192.11 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 193.05 Bn | 167.25 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 32.65 Bn |
| 10 | Propanc Biopharma | 357,002.35 | -1.65 Mn | - | 3.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.35 Mn |
| Dec 31, 2025 | 3.62 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | 5.58 Mn |
| Mar 31, 2025 | 4.34 Mn |
| Dec 31, 2024 | 4.15 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 3.79 Mn |
| Mar 31, 2024 | 3.69 Mn |
| Dec 31, 2023 | 3.76 Mn |
| Sep 30, 2023 | 3.13 Mn |
| Jun 30, 2023 | 3.16 Mn |
| Mar 31, 2023 | 3.06 Mn |
| Dec 31, 2022 | 2.99 Mn |
| Sep 30, 2022 | 2.82 Mn |
| Jun 30, 2022 | 3.06 Mn |
| Mar 31, 2022 | 3.12 Mn |
| Dec 31, 2021 | 3.04 Mn |
| Sep 30, 2021 | 2.37 Mn |
| Jun 30, 2021 | 3.08 Mn |
API Access
Propanc Biopharma Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();